Skip to Content

Positive Results with Filgotinib for Ulcerative Colitis from ECCO23

Filgotinib effectively maintains symptomatic remission and health-related quality of life for up to approximately 4 years among patients with ulcerative colitis.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top